Overview

Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

Status:
RECRUITING
Trial end date:
2030-06-30
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized and controlled phase 3 clinical trial.
Phase:
PHASE3
Details
Lead Sponsor:
Chigenovo Co., Ltd